BRI Biopharmaceutical Research Revenue and Competitors
Estimated Revenue & Valuation
- BRI Biopharmaceutical Research's estimated annual revenue is currently $24.8M per year.
- BRI Biopharmaceutical Research's estimated revenue per employee is $243,000
Employee Data
- BRI Biopharmaceutical Research has 102 Employees.
- BRI Biopharmaceutical Research grew their employee count by 3% last year.
BRI Biopharmaceutical Research's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Administrative Officer | Reveal Email/Phone |
2 | Managing Director (Toronto) | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
4 | Project Manager / Designer | Reveal Email/Phone |
5 | Project Manager | Reveal Email/Phone |
6 | Senior Project Manager | Reveal Email/Phone |
7 | Designer/ Project Manager | Reveal Email/Phone |
8 | BIM Manager / Project Manager | Reveal Email/Phone |
9 | Associate / Project Manager | Reveal Email/Phone |
10 | Project Manager | Reveal Email/Phone |
BRI Biopharmaceutical Research Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.1M | 87 | 2% | N/A | N/A |
#2 | $63.6M | 238 | -28% | N/A | N/A |
#3 | $21.6M | 89 | 13% | N/A | N/A |
#4 | $181M | 596 | 2% | N/A | N/A |
#5 | $168M | 553 | 6% | N/A | N/A |
#6 | $92.3M | 304 | -1% | N/A | N/A |
#7 | $141.5M | 466 | 7% | N/A | N/A |
#8 | $39.3M | 147 | 1% | N/A | N/A |
#9 | $68.7M | 257 | -7% | N/A | N/A |
#10 | $13.1M | 60 | -17% | N/A | N/A |
What Is BRI Biopharmaceutical Research?
Learn about working at BRI Biopharmaceutical Research Inc. Join LinkedIn today for free. See who you know at BRI Biopharmaceutical Research Inc, leverage your professional network, and get hired.
keywords:N/A
N/A
Total Funding
102
Number of Employees
$24.8M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BRI Biopharmaceutical Research News
2022-04-17 - Heat Biologics' Scorpion Subsidiary Announces Planned ...
Manhattan is the home of Kansas State University (K-State), its Biosecurity Research Institute (BRI), and the National Bio and Agro-Defense...
2022-03-30 - UCB Media Room: American Academy of Neurology (AAN) Annual Meeting
In the U.S., bri= varacetam* is approved for the treatment of partial ... =C2=B7 Real-world Study of Brivaracetam in the United States.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.8M | 102 | N/A | N/A |
#2 | $14.8M | 102 | N/A | N/A |
#3 | $16.3M | 102 | 9% | N/A |
#4 | $21.4M | 102 | -6% | N/A |
#5 | $15M | 102 | -5% | N/A |